<DOC>
	<DOCNO>NCT00067782</DOCNO>
	<brief_summary>The purpose clinical research study learn atazanavir associate serum LDL cholesterol HIV-infected subject follow substitution atazanavir previously administer protease inhibitor .</brief_summary>
	<brief_title>A Phase IIIB Study Evaluating Effect Serum Lipids Following Switch Atazanavir HIV Infected Subjects Evidencing Virologic Suppression Their First PI-Based Antiretroviral Therapy</brief_title>
	<detailed_description />
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Atazanavir Sulfate</mesh_term>
	<criteria>Key Must current HIV treatment regimen least 3 6 month prior study ( must one protease inhibitor , ritonavirboosted protease inhibitor , two nucleoside reverse transcriptase inhibitor ) must subject 's first PI ever receive Plasma HIV1 RNA level &lt; 50 c/mL within 3 6 month prior study start Fasting LDL cholesterol &gt; 130 mg/dL Key WOCBP use effective barrier contraception reason Women pregnant breast feed A life expectancy &lt; 12 month Presence newly diagnose HIVrelated OI medical condition require acute therapy time enrollment Cushing 's Syndrome Uncontrolled diabetes mellitus , history diabetic ketoacidosis hyperosmolar syndrome Untreated hypothyroidism hyperthyroidism Nephrotic syndrome significant proteinuria Obstructive liver disease Active alcohol substance abuse Proven suspect acute hepatitis 30 day prior study entry Intractable diarrhea ( great equal 6 loose stools/day least 7 consecutive day ) within 30 day prior study start History acute chronic pancreatitis Inability swallow capsule Presence cardiomyopathy Known history prolong QTc interval Any following : 1. clinical symptom potentially related heart block 2. heart rate &lt; 40 bpm 3. follow EKG abnormality : ) pause length &gt; 3 second ii ) second third degree AV heart block iii ) QTc interval &gt; 450 msec male iv ) QTc interval &gt; 470 msec female Fasting serum triglyceride level &gt; 750 mg/dL Any follow lab value within 2 week start study drug : 1. serum creatinine great equal 1.5 time upper limit normal 2. total serum lipase great equal 1.4 time upper limit normal 3. liver transaminase great equal 3 time upper limit normal 4. total serum bilirubin great equal 1.5 time upper limit normal Hypersensitivity component formulation study drug Use lipidlowering agent within 4 week prior study Use PIcontaining ARV regimen prior entry comprise one PI Inclusion NNRTI PIcontaining regimen Prisoners subject involuntary incarcerate treatment psychiatric physical illness</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2010</verification_date>
	<keyword>HIV</keyword>
	<keyword>Treatment Experienced</keyword>
</DOC>